
Everoglob 0.75mg Tablet
Marketer
Globela Pharma Pvt Ltd
Salt Composition
Everolimus (0.75mg)
Overview Everoglob 0.75mg Tablet
Transplant recipients use Globulin-R 0.75mg tablets to prevent organ rejection by modulating the immune system's response, facilitating organ acceptance. This medication also features in combination therapies for breast, pancreatic, lung, and kidney cancers. Dosage and duration for Globulin-R 0.75mg tablets must adhere strictly to the prescribed regimen. Administration can occur with or without food, but consistent daily timing is crucial. Overdosing may lead to serious adverse effects. Common side effects include infections (respiratory, urinary tract), fever, cough, fatigue, diarrhea. Persistent or bothersome side effects require immediate medical attention. Report any allergic reaction (rash, dyspnea, cough, edema) immediately. Seek medical counsel for increased thirst/urination, dyspnea, cough, fever, or before receiving vaccinations. Pre-treatment consultation with your physician is vital, particularly if you are on other medications or have pre-existing conditions. Pregnant or lactating individuals must inform their doctor before commencing treatment. Regular blood tests may be advised to monitor therapeutic effects. This medication may impact fertility in both sexes; consult your doctor regarding family planning.
Uses of Everoglob 0.75mg Tablet
Avoiding organ rejection after transplantation
Major Benefits of Everoglob 0.75mg Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Everoglob 0.75mg Tablet can be administered with or without food, although consistent timing is recommended.
Common Side effects of Everoglob 0.75mg Tablet:
- Infection
- Fever
- Cough
- Fatigue
- Diarrhea
- Upper respiratory tract infection
How to use Everoglob 0.75mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Everoglob 0.75mg Tablet can be consumed with or without food, although consistent timing is recommended.
How Everoglob 0.75mg Tablet works:
Everoglob 0.75mg tablets modulate the immune response, thereby reducing the risk of organ transplant rejection.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of alcohol consumption alongside Everoglob 0.75mg Tablet is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Everoglob 0.75mg tablets during pregnancy poses a confirmed risk to the fetus and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Maternal use of Everoglob 0.75mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Everoglob 0.75mg tablets may induce side effects that could impair driving ability. Tiredness is a frequent side effect of Everoglob 0.75mg tablets, potentially impacting driving safety.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely take Everoglob 0.75mg tablets without requiring a dosage change.
LiverCAUTION
Patients with liver impairment should use Everoglob 0.75mg tablets cautiously, potentially requiring dose modification. Physician consultation is advised. Everoglob 0.75mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Everoglob 0.75mg Tablet :
NA
Facts to Know About Everoglob 0.75mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Macrolide Antibiotics |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
